• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings

    2/23/24 10:25:13 AM ET
    $AER
    $AXTI
    $CRGE
    $MNPR
    Diversified Commercial Services
    Consumer Discretionary
    Semiconductors
    Technology
    Get the next $AER alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

    Following the market opening Friday, the Dow traded up 0.46% to 39,249.71 while the NASDAQ rose 0.20% to 16,073.78. The S&P 500 also rose, gaining, 0.41% to 5,107.74.
    Also Check This Out: Jim Cramer: Unity Software 'Had Problems,' But Zscaler Is A 'Good One' To Buy

     

    Leading and Lagging Sectors

     

    Utilities shares rose by 1.1% on Friday.

    In trading on Friday, energy shares fell by 1.1%.

     

    Top Headline

     

    AerCap Holdings N.V. (NYSE:AER) reported upbeat earnings for its fourth quarter on Friday.

    Total revenues and other income rose 4% to $1.899 billion, missing the consensus of $1.926 billion. Adjusted EPS of $3.11 beat the analyst consensus of $2.45.

     

    Equities Trading UP

     

    AXT, Inc. (NASDAQ:AXTI) shares shot up 79% to $4.0690 after the company reported better-than-expected fourth-quarter financial results.

    Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) got a boost, surging 56% to $7.97 after the company reported better-than-expected fourth-quarter financial results.

    Monopar Therapeutics Inc. (NASDAQ:MNPR) shares were also up, gaining 52% to $1.70 after the company announced preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.

     

    Equities Trading DOWN

     

    Sequans Communications S.A. (NYSE:SQNS) shares dropped 73% to $0.6995 after Renesas announced that it has terminated the previously announced MOU for a proposed acquisition of Sequans.

    Shares of Charge Enterprises, Inc. (NASDAQ:CRGE) were down 41% to $0.0430. Charge Enterprises announced decision of Nasdaq Hearings Panel to delist common shares.

    Upland Software, Inc. (NASDAQ:UPLD) was down, falling 39% to $2.67 after the company reported downbeat quarterly earnings.

     

    Commodities

     

    In commodity news, oil traded down 2.1% to $76.94 while gold traded up 0.3% at $2,036.30.

    Silver traded down 0.5% to $22.68 on Friday while copper fell 1.1% to $3.8560.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 climbed 0.5%, London’s FTSE 100 rose 0.3% while Spain’s IBEX 35 Index fell 0.1% The German DAX gained 0.4% French CAC 40 rose 0.8% while Italy’s FTSE MIB Index rose 1%.

    German economy contracted by 0.3% during the final quarter of 2023, while the Ifo Business Climate indicator for Germany edged higher to 85.5 in February from 85.2 in January. Median consumer expectations for the eurozone inflation over the next 12 months accelerated to 3.3% in January versus 3.2% in the prior month. The GfK Consumer Confidence indicator for the UK fell to -21 in February versus -19 in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Friday, with Hong Kong’s Hang Seng Index falling 0.10%, China’s Shanghai Composite Index gaining 0.55% and India’s S&P BSE Sensex gaining 0.1%.

    Chinese new home prices fell by 0.7% year-over-year for January versus a 0.4% fall a month ag.

     

    Economics

     

    Data on Baker Hughes rig count for the recent week will be released at 1 p.m. ET.

    Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

    Get the next $AER alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AER
    $AXTI
    $CRGE
    $MNPR

    CompanyDatePrice TargetRatingAnalyst
    AXT Inc
    $AXTI
    1/20/2026Buy → Hold
    Needham
    Monopar Therapeutics Inc.
    $MNPR
    1/9/2026$115.00Overweight
    Morgan Stanley
    AXT Inc
    $AXTI
    1/9/2026$18.00Buy → Neutral
    B. Riley Securities
    Sequans Communications S.A.
    $SQNS
    12/10/2025$18.00Buy
    Lake Street
    AerCap Holdings N.V.
    $AER
    12/9/2025$159.00Buy
    Truist
    Monopar Therapeutics Inc.
    $MNPR
    11/14/2025Strong Buy → Outperform
    Raymond James
    Monopar Therapeutics Inc.
    $MNPR
    11/10/2025$115.00Outperform
    Leerink Partners
    Sequans Communications S.A.
    $SQNS
    10/16/2025$13.00Buy
    B. Riley Securities
    More analyst ratings

    $AER
    $AXTI
    $CRGE
    $MNPR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Monopar Therapeutics Inc.

    SCHEDULE 13G/A - Monopar Therapeutics (0001645469) (Subject)

    2/6/26 9:54:43 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by AerCap Holdings N.V.

    6-K - AerCap Holdings N.V. (0001378789) (Filer)

    2/6/26 7:20:04 AM ET
    $AER
    Diversified Commercial Services
    Consumer Discretionary

    AXT Inc filed SEC Form 8-K: Leadership Update

    8-K - AXT INC (0001051627) (Filer)

    1/29/26 4:06:12 PM ET
    $AXTI
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Robinson Chandler acquired 62,815 shares (SEC Form 4)

    4 - Monopar Therapeutics (0001645469) (Issuer)

    1/30/26 2:31:04 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    Large owner Asher Daniel bought $222,513 worth of shares (42,260 units at $5.27) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/22/26 5:09:00 PM ET
    $SQNS
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AerCap Holdings N.V. Reports Record Financial Results for the Full Year 2025

    Net income of $633 million, or $3.79 per share, for the fourth quarter of 2025 and $3.8 billion, or $21.30 per share, for the full year 2025. Adjusted net income of $660 million, or $3.95 per share, for the fourth quarter of 2025 and $2.7 billion, or $15.37 per share, for the full year 2025.Quarterly dividend increased to $0.40 per share.DUBLIN, Feb. 6, 2026 /PRNewswire/ -- AerCap Holdings N.V. (NYSE:AER), the industry leader across all areas of aviation leasing, today reported strong financial results for the fourth quarter and full year ended December 31, 2025. "We are pleased to announce another strong quarter for AerCap, completing a year of record net income and earnings per share. Thes

    2/6/26 7:00:00 AM ET
    $AER
    Diversified Commercial Services
    Consumer Discretionary

    New Upland BA Insight Platform Delivers Integrated AI Search Experiences for Enterprises

    Upland Software, Inc. (NASDAQ:UPLD), a leader in AI-powered knowledge and content management software, today announced the Upland BA Insight Platform, reflecting a strategic investment in AI innovation. The new BA Insight Platform – incorporating the product's SmartHub, ConnectivityHub, AutoClassifier, Smart Preview, and Connectors – delivers search experiences that are more connected, more contextual, and more actionable. This launch reinforces the company's goal of empowering complex organizations with smarter, more integrated search capabilities for both traditional enterprise and next-generation AI environments. "While application connectors are important, our differentiation lies in

    2/3/26 9:05:00 AM ET
    $UPLD
    Computer Software: Prepackaged Software
    Technology

    Sequans Announces Conference Call to Review Fourth Quarter and Full Year 2025 Results

    Paris, France--(Newsfile Corp. - January 20, 2026) - Sequans Communications S.A. (NYSE:SQNS) a leading provider of 5G/4G cellular IoT semiconductor solutions and a pioneer in Bitcoin treasury, will release its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, during pre-market hours. Following the announcement, Sequans' management will host a conference call at 8:00 a.m. ET.Conference Call DetailsDate: Time:Dial in:Tuesday, February 10, 20268:00 a.m. ET / 14:00 CETLink Upon registration, participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.Those who wish to join the l

    1/20/26 8:00:00 AM ET
    $SQNS
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    Large owner Asher Daniel bought $222,513 worth of shares (42,260 units at $5.27) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/22/26 5:09:00 PM ET
    $SQNS
    Semiconductors
    Technology

    Large owner Asher Daniel bought $225,174 worth of shares (39,831 units at $5.65) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/20/26 5:41:51 PM ET
    $SQNS
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AXT downgraded by Needham

    Needham downgraded AXT from Buy to Hold

    1/20/26 9:03:45 AM ET
    $AXTI
    Semiconductors
    Technology

    Morgan Stanley initiated coverage on Monopar Therapeutics with a new price target

    Morgan Stanley initiated coverage of Monopar Therapeutics with a rating of Overweight and set a new price target of $115.00

    1/9/26 9:05:54 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AXT downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded AXT from Buy to Neutral and set a new price target of $18.00

    1/9/26 8:48:15 AM ET
    $AXTI
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Leadership Updates

    Live Leadership Updates

    View All

    Sequans Appoints Jason W. Cohenour to Board of Directors

    Paris, France--(Newsfile Corp. - June 30, 2025) - Sequans Communications S.A. (NYSE:SQNS), a leading innovator in cellular IoT semiconductor solutions, today announced the appointment of Jason W. Cohenour to its Board of Directors.Mr. Cohenour brings more than 30 years of executive leadership experience across sales, operations, and international mergers and acquisitions. He served as President, CEO, and Director of Sierra Wireless, Inc. (TSX:SW) (NASDAQ:SWIR) from 2005 to 2018, where he led a strategic transformation that created a global leader in the Internet of Things and drove company revenues to nearly USD $800 million. Prior to his CEO role, he held several senior positions at Sierra

    6/30/25 8:00:00 AM ET
    $CAMP
    $LTRX
    $RFIL
    Computer Communications Equipment
    Telecommunications
    Electrical Products
    Technology

    Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

    SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh "Raj" Asarpota has been appointed Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. He will succeed Kevin Herde, who is transitioning to an advisory role on the same date to support an effective transition.  "We thank Kevin for his commitment to Maravai and his leadership over the past eight years," said Susannah Gray, Audit Committee Chair, Maravai Board of Directors. "He has played an important role in shaping the company's foundati

    6/25/25 4:01:00 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors

    SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the appointment of Bernd Brust as Chief Executive Officer (CEO) and a member of the Board of Directors, effective immediately. Mr. Brust succeeds William "Trey" Martin III in these roles. "This leadership transition reflects Maravai's commitment to accelerating innovation, execution, and financial performance. Bernd brings more than 30 years of leadership experience in the life sciences industry, with a proven track record of transforming businesses into profitable, revenue-growing com

    6/9/25 8:30:00 AM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AER
    $AXTI
    $CRGE
    $MNPR
    Financials

    Live finance-specific insights

    View All

    AerCap Holdings N.V. Reports Record Financial Results for the Full Year 2025

    Net income of $633 million, or $3.79 per share, for the fourth quarter of 2025 and $3.8 billion, or $21.30 per share, for the full year 2025. Adjusted net income of $660 million, or $3.95 per share, for the fourth quarter of 2025 and $2.7 billion, or $15.37 per share, for the full year 2025.Quarterly dividend increased to $0.40 per share.DUBLIN, Feb. 6, 2026 /PRNewswire/ -- AerCap Holdings N.V. (NYSE:AER), the industry leader across all areas of aviation leasing, today reported strong financial results for the fourth quarter and full year ended December 31, 2025. "We are pleased to announce another strong quarter for AerCap, completing a year of record net income and earnings per share. Thes

    2/6/26 7:00:00 AM ET
    $AER
    Diversified Commercial Services
    Consumer Discretionary

    Sequans Announces Conference Call to Review Fourth Quarter and Full Year 2025 Results

    Paris, France--(Newsfile Corp. - January 20, 2026) - Sequans Communications S.A. (NYSE:SQNS) a leading provider of 5G/4G cellular IoT semiconductor solutions and a pioneer in Bitcoin treasury, will release its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, during pre-market hours. Following the announcement, Sequans' management will host a conference call at 8:00 a.m. ET.Conference Call DetailsDate: Time:Dial in:Tuesday, February 10, 20268:00 a.m. ET / 14:00 CETLink Upon registration, participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.Those who wish to join the l

    1/20/26 8:00:00 AM ET
    $SQNS
    Semiconductors
    Technology

    AXT Updates Revenue Expectations for Fourth Quarter 2025 and Announces Earnings Date for Feb. 19, 2026

    Company to present at 28th Annual Needham Growth Conference on Jan. 14 AXT, Inc. (NASDAQ:AXTI), a leading manufacturer of compound semiconductor wafer substrates, today updated revenue expectations for the fourth quarter 2025. The company expects revenue to be in the range of $22.5 to $23.5 million, primarily due to fewer export control permits for indium phosphide being issued by China's Ministry of Commerce than previously expected. "While we are disappointed that we were not able to ship indium phosphide substrates to fulfil more customer orders in December, we continue to work diligently with the Ministry of Commerce on the export permit process and are hopeful that we will receive

    1/8/26 4:05:00 PM ET
    $AXTI
    Semiconductors
    Technology

    $AER
    $AXTI
    $CRGE
    $MNPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Maravai LifeSciences Holdings Inc.

    SC 13G/A - MARAVAI LIFESCIENCES HOLDINGS, INC. (0001823239) (Subject)

    11/14/24 7:49:19 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by AerCap Holdings N.V.

    SC 13G/A - AerCap Holdings N.V. (0001378789) (Subject)

    11/14/24 4:14:32 PM ET
    $AER
    Diversified Commercial Services
    Consumer Discretionary

    $AER
    $AXTI
    $CRGE
    $MNPR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care